The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease

American Heart Journal

Volumn 153, Issue 2, 2007, Pages 244.e1-244.e5

  Sheen, Victoria ^a   Bhalla, Vikas ^a   Tulua Tata, Alisi ^a   Bhalla, Meenakshi A ^a   Weiss, Danielle ^a   Chiu, Albert ^a   Abdeen, Omaran ^a   Mullaney, Scott ^a   Maisel, Alan ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE OVERLOAD; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PLASMA VOLUME; PRIORITY JOURNAL; SEX RATIO; SYSTOLIC BLOOD PRESSURE;

EID: 33846261986     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.10.041     Document Type: Article

References (22)

1. Collins A.J. Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325 (2003) 163-167
2. Iwashima Y., Horio T., Takami Y., et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 40 (2002) 974-982
3. Kouw P.M., Kooman J.P., Cheriex E.C., et al. Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 4 (1993) 98-104
4. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
5. Maeda K., Takayoshi T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
6. Nagagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
7. Krishnaswamy P., Lubein E., Clopton P., et al. Utility of B-type natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a Veterans Hospital. Am J Med 111 (2001) 274-279
8. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141 (2001) 367-374
9. Cataliotti A., Malatino L.S., Jougasaki M., et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76 (2001) 1111-1119
10. Goto T., Takase H., Toriyama T., et al. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92 (2002) 610-615
11. Naganuma T., Sugimura K., Wada S., et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22 (2002) 437-444
12. Zoccali C., Mallamaci F., Benedetto F.A., et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12 (2001) 1508-1515
13. Feigenbaum H. Echocardiography. 6th ed. (1999), Lea and Febiger, Philadelphia (PA)
14. Schiller N.B., Acquatella H., Ports T.A., et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 60 (1979) 547
15. Lubien E., DeMaria A., Krishnaswamy, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105 (2002) 595-601
16. Wu A.H.B., Packer M., Smith A., et al. Analytical and clinical evaluation of the Bayer ADVIA centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 50 (2004) 867-873
17. Hakim R.M., and Siami G.A. Plasmapheresis, in handbook of dialysis. 2nd Ed. In: Daugirdas J.T., and Ing T.S. (Eds) (1994), Little, Brown and Company, Boston 220
18. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39 (2002) 131-138
19. Dries D.L., Exner D.V., Domanski M.J., et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
20. Wegner M., Ganten D., and Stasch J.P. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats. Hypertens Res 19 (1996) 229-238
21. Ozaki J., Shimizu H., Hashimoto Y., et al. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides. Eur J Pharmacol 370 (1999) 307-312
22. Maisel A.S., McCord J., Nowak R.M., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41 (2003) 2010-2017